retatrutide glp-1 receptor agonist triple gip glucagon Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight ADA 2026: Retatrutide Revolution

Here, we demonstrate that gut-selective and systemic inhibition of DPP-4 activity reduces postprandial TG excursion in young mice

It also helps to be honest with yourself about how much and how often you drink

Traumatic Brain Injury In the Renegade Research Roundtable, Dr

Compare minoxidil vs finasteride, including how each works, differences in treatment approach, potential side effects, and what men should know about hair loss options

The pharmacokinetic bottom line is that orforglipron behaves, in the body and in the lab, like a drug-like small molecule that happens to hit an incretin receptor not like a peptide that has been coaxed into oral form

Zo Lees, PhD Metabolic Medicine PhD Metabolic Medicine | MSc Diabetes | BSc (Hons) Biomedical Sciences | Dr